 Finally, Pestell discovered CCR5 governs cancer metastasis in both breast and prostate cancer  providing the potential for therapeutic targeting with issued patents in this domain.Pestell is the founder of two biotechnology companies (ProstaGene and LightSeed) and holds patents in the areas of cancer diagnostics, therapeutics and technologies.He is married to Anna Pestell and has two children.